Table 1.
Variable | Value | Reference |
---|---|---|
Cost∗ | ||
Transplant | ||
Inpatient costs for ECMO-bridged transplant | $636,023 | Patient-level data |
Inpatient costs for non–ECMO-bridged transplant | $538,928 | Patient-level data |
LVAD | ||
Inpatient costs for ECMO-bridged LVAD | $769,471 | Patient-level data |
Inpatient costs for non–ECMO-bridged LVAD | $325,242 | Patient-level data |
Annual cost after transplant | ||
Year 1 | $155,512 | Long and colleagues, 201412 |
Year 2 and beyond | $34,905 | Long and colleagues, 201412 |
Annual cost after LVAD | ||
Year 1 | $164,831 | Long and colleagues, 201412 |
Year 2 and beyond | $46,835 | Long and colleagues, 201412 |
End-of-life care costs | $62,324 | Long and colleagues, 201412 |
QALY weights | ||
Postheart transplant | ||
NYHA I | 0.90 | Göhler and colleagues, 200913 |
NYHA II | 0.83 | Göhler and colleagues, 200913 |
NYHA III | 0.74 | Göhler and colleagues, 200913 |
NYHA IV | 0.60 | Göhler and colleagues, 200913 |
Post-LVAD | ||
ECMO-bridged QALY | 0.82 | Unai and colleagues, 201714 |
Non–ECMO-bridged QALY | 0.79 | Unai and colleagues, 201714 |
Survival | ||
Years after transplant | ||
ECMO-bridged survival | ||
1 Year | 0.707 | DeFilippis and colleagues, 202115 |
2 Year | 0.666 | DeFilippis and colleagues, 202115 |
5 Year | 0.618 | DeFilippis and colleagues, 202115 |
Non–ECMO-bridged survival | ||
1 Year | 0.92 | Mishra and colleagues, 201716 |
3 Year | 0.87 | Mishra and colleagues, 201716 |
5 Year | 0.81 | Mishra and colleagues, 201716 |
7 Year | 0.77 | Mishra and colleagues, 201716 |
Years after LVAD placement | ||
ECMO-bridged survival | ||
1 Year | 0.692 | DeFilippis and colleagues, 202115 |
2 Year | 0.626 | DeFilippis and colleagues, 202115 |
5 Year | 0.565 | DeFilippis and colleagues, 202115 |
Non–ECMO-bridged survival | ||
1 Year | 0.88 | Han and colleagues, 201817 |
ECMO, Extracorporeal membranous oxygenation; LVAD, left ventricular assist device; QALY, quality-adjusted life years; NYHA, New York Heart Association.
Cost in 2020 US dollars.